3.24.1.1.u2 html 138 303 1 false 61 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.petrospharma.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedStatementsOfChangesInConvertibleRedeemablePreferredStockAndStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.petrospharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - Nature of Operations, Basis of Presentation, Liquidity and Going Concern Sheet http://www.petrospharma.com/role/DisclosureNatureOfOperationsBasisOfPresentationLiquidityAndGoingConcern Nature of Operations, Basis of Presentation, Liquidity and Going Concern Notes 7 false false R8.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 10301 - Disclosure - Accounts Receivable, net Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNet Accounts Receivable, net Notes 9 false false R10.htm 10401 - Disclosure - Inventories Sheet http://www.petrospharma.com/role/DisclosureInventories Inventories Notes 10 false false R11.htm 10501 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 11 false false R12.htm 10601 - Disclosure - Intangible Assets Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssets Intangible Assets Notes 12 false false R13.htm 10701 - Disclosure - Accrued Expenses Sheet http://www.petrospharma.com/role/DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 10801 - Disclosure - Debt Sheet http://www.petrospharma.com/role/DisclosureDebt Debt Notes 14 false false R15.htm 10901 - Disclosure - Stockholders' Equity Sheet http://www.petrospharma.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 11001 - Disclosure - Stock Options Sheet http://www.petrospharma.com/role/DisclosureStockOptions Stock Options Notes 16 false false R17.htm 11101 - Disclosure - Common Stock Warrants Sheet http://www.petrospharma.com/role/DisclosureCommonStockWarrants Common Stock Warrants Notes 17 false false R18.htm 11201 - Disclosure - Dilutive convertible securities Sheet http://www.petrospharma.com/role/DisclosureDilutiveConvertibleSecurities Dilutive convertible securities Notes 18 false false R19.htm 11301 - Disclosure - Marketing, Licensing and Distribution Agreements Sheet http://www.petrospharma.com/role/DisclosureMarketingLicensingAndDistributionAgreements Marketing, Licensing and Distribution Agreements Notes 19 false false R20.htm 11401 - Disclosure - Commitments and Contingencies Sheet http://www.petrospharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 11501 - Disclosure - Segment Information Sheet http://www.petrospharma.com/role/DisclosureSegmentInformation Segment Information Notes 21 false false R22.htm 11601 - Disclosure - Private Placement Sheet http://www.petrospharma.com/role/DisclosurePrivatePlacement Private Placement Notes 22 false false R23.htm 11701 - Disclosure - Fair Value Measurements Sheet http://www.petrospharma.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 23 false false R24.htm 11801 - Disclosure - Subsequent Events Sheet http://www.petrospharma.com/role/DisclosureSubsequentEvents Subsequent Events Notes 24 false false R25.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 25 false false R26.htm 30303 - Disclosure - Accounts Receivable, net (Tables) Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNetTables Accounts Receivable, net (Tables) Tables http://www.petrospharma.com/role/DisclosureAccountsReceivableNet 26 false false R27.htm 30403 - Disclosure - Inventories (Tables) Sheet http://www.petrospharma.com/role/DisclosureInventoriesTables Inventories (Tables) Tables http://www.petrospharma.com/role/DisclosureInventories 27 false false R28.htm 30503 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 28 false false R29.htm 30603 - Disclosure - Intangible Assets (Tables) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.petrospharma.com/role/DisclosureIntangibleAssets 29 false false R30.htm 30703 - Disclosure - Accrued Expenses (Tables) Sheet http://www.petrospharma.com/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.petrospharma.com/role/DisclosureAccruedExpenses 30 false false R31.htm 30803 - Disclosure - Debt (Tables) Sheet http://www.petrospharma.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.petrospharma.com/role/DisclosureDebt 31 false false R32.htm 31003 - Disclosure - Stock Options (Tables) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsTables Stock Options (Tables) Tables http://www.petrospharma.com/role/DisclosureStockOptions 32 false false R33.htm 31103 - Disclosure - Common Stock Warrants (Tables) Sheet http://www.petrospharma.com/role/DisclosureCommonStockWarrantsTables Common Stock Warrants (Tables) Tables http://www.petrospharma.com/role/DisclosureCommonStockWarrants 33 false false R34.htm 31203 - Disclosure - Dilutive convertible securities (Tables) Sheet http://www.petrospharma.com/role/DisclosureDilutiveConvertibleSecuritiesTables Dilutive convertible securities (Tables) Tables http://www.petrospharma.com/role/DisclosureDilutiveConvertibleSecurities 34 false false R35.htm 31503 - Disclosure - Segment Information (Tables) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.petrospharma.com/role/DisclosureSegmentInformation 35 false false R36.htm 31703 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.petrospharma.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.petrospharma.com/role/DisclosureFairValueMeasurements 36 false false R37.htm 40101 - Disclosure - Nature of Operations, Basis of Presentation, Liquidity and Going Concern - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureNatureOfOperationsBasisOfPresentationLiquidityAndGoingConcernAdditionalInformationDetails Nature of Operations, Basis of Presentation, Liquidity and Going Concern - Additional Information (Details) Details 37 false false R38.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.petrospharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies 38 false false R39.htm 40301 - Disclosure - Accounts Receivable, net (Details) Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNetDetails Accounts Receivable, net (Details) Details http://www.petrospharma.com/role/DisclosureAccountsReceivableNetTables 39 false false R40.htm 40302 - Disclosure - Accounts Receivable, net - Additional information (Details) Sheet http://www.petrospharma.com/role/DisclosureAccountsReceivableNetAdditionalInformationDetails Accounts Receivable, net - Additional information (Details) Details 40 false false R41.htm 40401 - Disclosure - Inventories (Details) Sheet http://www.petrospharma.com/role/DisclosureInventoriesDetails Inventories (Details) Details http://www.petrospharma.com/role/DisclosureInventoriesTables 41 false false R42.htm 40402 - Disclosure - Inventories - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureInventoriesAdditionalInformationDetails Inventories - Additional Information (Details) Details 42 false false R43.htm 40501 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.petrospharma.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables 43 false false R44.htm 40601 - Disclosure - Intangible Assets (Details) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) Details http://www.petrospharma.com/role/DisclosureIntangibleAssetsTables 44 false false R45.htm 40602 - Disclosure - Intangible Assets - Future annual amortization (Details) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsFutureAnnualAmortizationDetails Intangible Assets - Future annual amortization (Details) Details 45 false false R46.htm 40603 - Disclosure - Intangible Assets - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureIntangibleAssetsAdditionalInformationDetails Intangible Assets - Additional Information (Details) Details 46 false false R47.htm 40701 - Disclosure - Accrued Expenses (Details) Sheet http://www.petrospharma.com/role/DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.petrospharma.com/role/DisclosureAccruedExpensesTables 47 false false R48.htm 40801 - Disclosure - Debt - Promissory Note (Details) Sheet http://www.petrospharma.com/role/DisclosureDebtPromissoryNoteDetails Debt - Promissory Note (Details) Details 48 false false R49.htm 40802 - Disclosure - Debt - Future minimum principal payments (Details) Sheet http://www.petrospharma.com/role/DisclosureDebtFutureMinimumPrincipalPaymentsDetails Debt - Future minimum principal payments (Details) Details 49 false false R50.htm 40901 - Disclosure - Stockholders' Equity - Number of shares held (Details) Sheet http://www.petrospharma.com/role/DisclosureStockholdersEquityNumberOfSharesHeldDetails Stockholders' Equity - Number of shares held (Details) Details 50 false false R51.htm 41001 - Disclosure - Stock Options - Summary of stock options (Details) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsSummaryOfStockOptionsDetails Stock Options - Summary of stock options (Details) Details 51 false false R52.htm 41002 - Disclosure - Stock Options - Additional Information (Details) Sheet http://www.petrospharma.com/role/DisclosureStockOptionsAdditionalInformationDetails Stock Options - Additional Information (Details) Details 52 false false R53.htm 41101 - Disclosure - Common Stock Warrants - Summary of warrants (Details) Sheet http://www.petrospharma.com/role/DisclosureCommonStockWarrantsSummaryOfWarrantsDetails Common Stock Warrants - Summary of warrants (Details) Details 53 false false R54.htm 41201 - Disclosure - Dilutive convertible securities - Potentially dilutive securities convertible into common shares that were excluded from the calculation of diluted net income (loss) per share (Details) Sheet http://www.petrospharma.com/role/DisclosureDilutiveConvertibleSecuritiesPotentiallyDilutiveSecuritiesConvertibleIntoCommonSharesThatWereExcludedFromCalculationOfDilutedNetIncomeLossPerShareDetails Dilutive convertible securities - Potentially dilutive securities convertible into common shares that were excluded from the calculation of diluted net income (loss) per share (Details) Details 54 false false R55.htm 41301 - Disclosure - Marketing, Licensing and Distribution Agreements - Vivus (Details) Sheet http://www.petrospharma.com/role/DisclosureMarketingLicensingAndDistributionAgreementsVivusDetails Marketing, Licensing and Distribution Agreements - Vivus (Details) Details http://www.petrospharma.com/role/DisclosureMarketingLicensingAndDistributionAgreements 55 false false R56.htm 41401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.petrospharma.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.petrospharma.com/role/DisclosureCommitmentsAndContingencies 56 false false R57.htm 41501 - Disclosure - Segment Information (Details) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationDetails Segment Information (Details) Details http://www.petrospharma.com/role/DisclosureSegmentInformationTables 57 false false R58.htm 41502 - Disclosure - Segment Information - Net Sales by Geographic region (Details) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationNetSalesByGeographicRegionDetails Segment Information - Net Sales by Geographic region (Details) Details 58 false false R59.htm 41503 - Disclosure - Segment Information - Segment assets (Details) Sheet http://www.petrospharma.com/role/DisclosureSegmentInformationSegmentAssetsDetails Segment Information - Segment assets (Details) Details 59 false false R60.htm 41601 - Disclosure - Private Placement (Details) Sheet http://www.petrospharma.com/role/DisclosurePrivatePlacementDetails Private Placement (Details) Details http://www.petrospharma.com/role/DisclosurePrivatePlacement 60 false false R61.htm 41701 - Disclosure - Fair Value Measurements (Details) Sheet http://www.petrospharma.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.petrospharma.com/role/DisclosureFairValueMeasurementsTables 61 false false R62.htm 41702 - Disclosure - Fair Value Measurements - Change in the fair value of financial liabilities (Details) Sheet http://www.petrospharma.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfFinancialLiabilitiesDetails Fair Value Measurements - Change in the fair value of financial liabilities (Details) Details 62 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: ptpi:MinimumTradingDaysAfterDateThatInitialRegistrationStatementForConsideringFirstTradingDayOfCalendarMonth, ptpi:NumberOfTradingDaysImmediatelyPriorToAmortizationPaymentIsDueConsideredForCalculatingConversionPrice, us-gaap:RevenuePracticalExpedientFinancingComponent - tmb-20240331x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - tmb-20240331x10q.htm 9 tmb-20240331.xsd tmb-20240331_cal.xml tmb-20240331_def.xml tmb-20240331_lab.xml tmb-20240331_pre.xml tmb-20240331x10q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true